DOSSIER · 13F-HR · Q1 2026

Kalehua Capital Management LLC

$260M in tracked AUM across 50 positions as of Q1 2026.

KC
CIK 0002106181 · last filed Mar 31, 2026
Total AUM
$260M
as of Q1 2026
Holdings
50
positions
Whale Score
59
59
tracked
Activity
no data
changes this Q
AI Analysis · Q1 2026

Kalehua Capital Management LLC filed its latest 13F-HR for Q1 2026. See the latest holdings and position changes below.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight
01
BOXX
EA SERIES TRUST
$39M337K15.1%
02
XFOR
X4 Pharmaceuticals Inc
$31M7.4M11.8%
03
SRZN
Surrozen Inc
$22M770K8.6%
04
RLAY
Relay Therapeutics Inc
$18M1.8M6.9%
05
SION
Sionna Therapeutics Inc
$16M394K6.1%
06
MANE
Veradermics Inc
$16M249K6.0%
07
ACRS
ACLARIS THERAPEUTICS INC
$12M3.2M4.6%
08
ORKA
Oruka Therapeutics Inc
$12M237K4.5%
09
N69605108
Pharvaris NV
$11M398K4.3%
10
IKT
Inhibikase Therapeutics Inc
$11M6.5M4.2%

Filing history

2026Q1Mar 31
$260M 157.1%
50 positionsView →
2025Q4Dec 31
$101M
19 positionsView →